Skip to content
Link copied to clipboard
Link copied to clipboard

Lawsuit could challenge trust in Ozempic and other popular weight loss drugs

Dozens of patients who suffered gastrointestinal problems after taking these drugs brought lawsuits alleging that these companies failed to properly warn patients about the risks.

FILE - The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. Even as millions of older adults clamor for drugs such as Ozempic and Wegovy, monthly use of the medications known as GLP-1 receptor agonists soared nearly 600% between 2020 and 2023 in people under 25 – and as young as 12. (AP Photo/David J. Phillip, File)
FILE - The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. Even as millions of older adults clamor for drugs such as Ozempic and Wegovy, monthly use of the medications known as GLP-1 receptor agonists soared nearly 600% between 2020 and 2023 in people under 25 – and as young as 12. (AP Photo/David J. Phillip, File)Read moreDavid J. Phillip / AP
    by Ana Santos Rutschman, The Conversation
    Published